Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Extended Efficacy of Low-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Intermediate-Risk Kidney Transplant Recipients: Two-Year Follow-Up.

Halim MA, Gheith OA, Makkeya Y, Nagib AM, Atta AF, Emam M, Yehia A, Said T, Nair P, Al-Otaibi T.

Exp Clin Transplant. 2019 Jan 21. doi: 10.6002/ect.2018.0020. [Epub ahead of print]

2.

Gene-based molecular characterization of cox1 and pnad5 in Hymenolepis nana isolated from naturally infected mice and rats in Saudi Arabia.

Metwally DM, Al-Enezy HA, Al-Turaiki IM, El-Khadragy MF, Yehia HM, Al-Otaibi TT.

Biosci Rep. 2019 Feb 8;39(2). pii: BSR20181224. doi: 10.1042/BSR20181224. Print 2019 Feb 28.

PMID:
30670630
3.

Prevalence of obstructive sleep apnea in children with sickle cell disease at a tertiary hospital in Saudi Arabia.

Al-Otaibi T, Al-Qwaiee M, Faraidi H, Batniji F, Al-Otaibi F, Al-Harbi A.

Saudi Med J. 2017 Jun;38(6):616-620. doi: 10.15537/smj.2017.6.19492.

4.

Sirolimus-Induced Combined Posterior Reversible Encephalopathy Syndrome and Lymphocytic Pneumonitis in a Renal Transplant Recipient: Case Report and Review of the Literature.

Gheith O, Cerna M, Halim MA, Nampoory N, Al-Otaibi T, Nair P, Said T, Atteya HA, Katchy K.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):170-174. Review.

5.

Bariatric Surgery in Renal Transplant Patients.

Gheith O, Al-Otaibi T, Halim MA, Mahmoud T, Mosaad A, Yagan J, Zakaria Z, Rida S, Nair P, Hassan R.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):164-169.

6.

Successful Cost-Effective Prevention of Cytomegalovirus Disease in Kidney Transplant Recipients Using Low-Dose Valganciclovir.

Gheith O, Halim MA, Al-Otaibi T, Mansour H, Mosaad A, Atteya HA, Zakaria Z, Said T, Nair P, Nampoory N.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):156-163.

7.

Early Versus Late Acute Antibody-Mediated Rejection Among Renal Transplant Recipients in Terms of Response to Rituximab Therapy: A Single Center Experience.

Gheith O, Al-Otaibi T, Halim MA, Mahmoud T, Nair P, Monem MA, Al-Waheeb S, Hassan R, Nampoory N.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):150-155.

8.

Triplet Pregnancy in a Diabetic Mother With Kidney Transplant: Case Report and Review of the Literature.

Mahmoud T, Mujaibel K, Attia H, Zakaria Z, Yagan J, Gheith O, Halim MA, Nair P, Al-Otaibi T.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):139-146. Review.

9.

Annual Data for Kidney Transplant Services in Kuwait (2015).

Makkeyah YM, Al-Otaibi T, Nampoory N, Nair P, Al-Mousawi M, Samhan M, Gawish A, Said T, Halim MA, Gheith O.

Exp Clin Transplant. 2017 Feb;15(Suppl 1):28-31.

10.

Recurrent Urinary Tract Infection Among Renal Transplant Recipients: Risk Factors and Long-Term Outcome.

Tawab KA, Gheith O, Al Otaibi T, Nampoory N, Mansour H, Halim MA, Nair P, Said T, Abdelmonem M, El-Sayed A, Awadain W.

Exp Clin Transplant. 2017 Apr;15(2):157-163. doi: 10.6002/ect.2016.0069. Epub 2016 Dec 22.

11.

Hepatitis C Virus in the Renal Transplant Population: An Update With Focus on the New Era of Antiviral Regimens.

Gheith O, Halim MA, Othman N, Al-Otaibi T, Nair P, Nampoory N.

Exp Clin Transplant. 2017 Feb;15(1):10-20. doi: 10.6002/ect.2015.0341. Epub 2016 Dec 2. Review.

12.

Efficacy and Safety of Low-Dose Versus Standard-Dose Valganciclovir for Prevention of Cytomegalovirus Disease in Intermediate-Risk Kidney Transplant Recipients.

Halim MA, Al-Otaibi T, Gheith O, Adel H, Mosaad A, Hasaneen AA, Zakaria Z, Makkeya Y, Said T, Nair P.

Exp Clin Transplant. 2016 Oct;14(5):526-534. doi: 10.6002/ect.2015.0305. Epub 2016 Jun 15.

13.

Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.

Halim MA, Al-Otaibi T, Gheith O, Mosaad A, Zakaria Z, Said T, Nair P, Nampoory NM.

Exp Clin Transplant. 2016 Feb;14(1):58-65.

14.

Delayed Graft Function in Living-Donor Kidney Transplant: A Middle Eastern Perspective.

Al Otaibi T, Ahmadpoor P, Allawi AA, Habhab WT, Khatami MR, Nafar M, Glotz D.

Exp Clin Transplant. 2016 Feb;14(1):1-11. Review.

15.

First study of pattern of anaphylaxis in a large tertiary care hospital in Saudi Arabia.

Sheikh F, Amin R, Rehan Khaliq AM, Al Otaibi T, Al Hashim S, Al Gazlan S.

Asia Pac Allergy. 2015 Oct;5(4):216-21. doi: 10.5415/apallergy.2015.5.4.216. Epub 2015 Oct 28.

16.

Diabetic kidney disease: world wide difference of prevalence and risk factors.

Gheith O, Farouk N, Nampoory N, Halim MA, Al-Otaibi T.

J Nephropharmacol. 2015 Oct 9;5(1):49-56. eCollection 2016. Review.

17.

Human leukocyte antigen Cw7-mediated protection against polyoma BK virus in renal transplant recipients who received grafts from antigen-positive donors.

Gheith O, Al-Otaibi T, Zakaria Z, Abdel Halim M, Nampoory N.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:383-7.

PMID:
25894195
18.

Acute cardiac tamponade: an unusual cause of acute renal failure in a renal transplant recipient.

Nampoory N, Gheith O, Al-Otaibi T, Halim M, Nair P, Said T, Mosaad A, Al-Sayed Z, Alsayed A, Yagan J.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:242-6.

PMID:
25894163
19.

Human leukocyte antigen-DR mismatched pediatric renal transplant: patient and graft outcome with different kidney donor sources.

Al-Otaibi T, Gheith O, Mosaad A, Nampoory MR, Halim M, Said T, Nair P.

Exp Clin Transplant. 2015 Apr;13 Suppl 1:117-23.

PMID:
25894139
20.

Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.

Halim MA, Al-Otaibi T, Gheith O, Zkaria Z, Mosaad A, Said T, Nair P, Nampoory N.

Exp Clin Transplant. 2014 Dec;12(6):528-33.

21.

Recurrent Focal Segmental Glomerulosclerosis and Abatacept: Case Report.

Alkandari O, Nampoory N, Nair P, Atta A, Zakaria Z, Mossad A, Yagan J, Al-Otaibi T.

Exp Clin Transplant. 2016 Aug;14(4):456-9. doi: 10.6002/ect.2014.0154. Epub 2014 Nov 27.

22.

Long-acting erythropoietin stimulating agents for persistent anemia after kidney transplant: risk factors and outcome.

Al-Otaibi T, Gheith O, Halim MA, Abu Attia H, Mansour H, Said T, Nair P, Balaha M, Nampoory MR.

Exp Clin Transplant. 2014 Jun;12(3):220-6.

23.

Bilateral chylothorax in a renal transplant recipient: case report and literature review.

Gheith O, Al Otaibi T, Nampoory MR, Attia H, Halim M, Said T, Nair P, Balaha M, Awadein W, Zakariya Z, Aboatteya H, Moideenkutty N.

Exp Clin Transplant. 2014 Apr;12(2):148-51. Review.

24.

Protracted febrile myalgia syndrome in a kidney transplant recipient with familial Mediterranean fever.

Abdel Halim MM, Al-Otaibi T, Donia F, Gheith O, Asif P, Nawas M, Rashad RH, Said T, Nair P, Nampoory N.

Exp Clin Transplant. 2015 Apr;13(2):188-92. doi: 10.6002/ect.2013.0244. Epub 2014 Mar 19.

25.

Combined liver and kidney transplantation in primary hyperoxaluria: a report of three cases and review of the literature.

Nair P, Al-Otaibi T, Nampoory N, Al-Qabandi W, Said T, Halim MA, Gheith O.

Saudi J Kidney Dis Transpl. 2013 Sep;24(5):969-75. Review.

26.

Effective therapy for acute antibody-mediated rejection with mild chronic changes: case report and review of the literature.

Gheith O, Al-Otaibi T, Nampoory N, Halim M, Nair P, Saied T, Al-Waheeb S, Muzeirei I, Ibraheim M.

Exp Clin Transplant. 2012 Aug;10(4):406-9. doi: 10.6002/ect.2011.0153. Epub 2012 Jun 29. Review.

27.

Successful management of critical illness polyneuropathy and myopathy in renal transplant recipients.

Gheith O, Al Otaibi T, Halim M, Said T, Nair P, Balaha M, Abd-el-Tawab K, Zakareya Z, Hosni W, Nampoory MR.

Exp Clin Transplant. 2012 Feb;10(1):62-6. Erratum in: Exp Clin Transplant. 2012 Apr;10(2):190. Abdelhalim, Medhat [corrected to Halim, Medhat].

28.

Late acute antibody mediated rejection after nine years of renal transplantation.

Halim MA, Al-Otaibi T, Al-Waheeb S, Tawab KA, El Kholy O, Nair P, Said T, Narayanan Nampoory MR.

Saudi J Kidney Dis Transpl. 2010 Nov;21(6):1111-4.

29.

Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.

Said T, Al-Otaibi T, Al-Wahaib S, Francis I, Nair MP, Halim MA, El-Sayed A, Nampoory MR.

Transplant Proc. 2010 Apr;42(3):814-6. doi: 10.1016/j.transproceed.2010.02.029.

PMID:
20430179
30.

Serial soluble CD30 measurements as a predictor of kidney graft outcome.

Halim MA, Al-Otaibi T, Al-Muzairai I, Mansour M, Tawab KA, Awadain WH, Balaha MA, Said T, Nair P, Nampoory MR.

Transplant Proc. 2010 Apr;42(3):801-3. doi: 10.1016/j.transproceed.2010.03.033.

PMID:
20430176
31.

Toxic tacrolimus blood levels with rifampin administration in a renal transplant recipient.

Abdel Halim M, Al-Otaibi T, Gheith O, El-Kholy O, Abdel Tawab K, Said T, Nair P, Nampoory MR.

Ann Transplant. 2010 Jan-Mar;15(1):57-60.

PMID:
20305320
32.

Erythema nodosum in renal transplant recipients: multiple cases and review of literature.

Gheith O, Al-Otaibi T, Tawab KA, Said T, Balaha MA, Halim MA, Nair MP, Nampoory MR.

Transpl Infect Dis. 2010 Apr;12(2):164-8. doi: 10.1111/j.1399-3062.2009.00474.x. Epub 2009 Dec 9. Review.

PMID:
20002354
33.

Active management of post-renal transplantation BK virus nephropathy: preliminary report.

Halim MA, Al-Otaibi T, El-Kholy O, Gheith OA, Al-Waheeb S, Szucs G, Pacsa A, Balaha MA, Hasaneen H, Said T, Nair P, Nampoory MR.

Transplant Proc. 2009 Sep;41(7):2850-2. doi: 10.1016/j.transproceed.2009.07.017.

PMID:
19765455
34.

Early sirolimus therapy in renal transplant recipients at high risk: is it justified?

Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Al-Waheeb S, Hasaneen H, Awadain WH, Nawas KM, El-Sayed A, Said T, Nair MP, Nampoory MR.

Transplant Proc. 2009 Sep;41(7):2784-8. doi: 10.1016/j.transproceed.2009.07.015.

PMID:
19765435
35.

Long-term follow-up of 100 high-risk renal transplant recipients converted from calcineurin inhibitors to sirolimus: a single center experience.

Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Tawab KA, Balaha MA, Abraham M, Said T, Nair MP, Al-Waheeb S, Al-Muzairai I, Nampoory MR.

Transplant Proc. 2009 Jun;41(5):1666-70. doi: 10.1016/j.transproceed.2009.01.100.

PMID:
19545704
36.

De-novo [corrected] post renal transplantation inflammatory bowel disease.

Halim MA, Al-Otaibi T, Elsisi A, El-Sayed A, Nair P, Said T, Balaha MA, Nampoory MR.

Saudi J Kidney Dis Transpl. 2008 Jul;19(4):624-6.

37.

Contrast media nephropathy: in depth review.

Hussain N, Al Otaibi T, Nampoory MR.

Saudi J Kidney Dis Transpl. 2008 Mar;19(2):174-82. Review. No abstract available.

38.

Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report.

Al Otaibi T, Al Sagheir A, Ludwin D, Meyer R.

Transplant Proc. 2007 May;39(4):1276-7.

PMID:
17524952
39.

Single daily dose administration of cyclosporine in renal transplant recipients.

Halim MA, Said T, Al-Otaibi T, Eleawa S, Al-Maged H, Gawish AE, Nair P, Al-Muzairai I, Nampoory MR, Al-Mousawi M.

Transplant Proc. 2007 May;39(4):1225-7.

PMID:
17524939
40.

Lymphedema: an unusual complication of sirolimus therapy.

Al-Otaibi T, Ahamed N, Nampoory MR, Al-Kandari N, Nair P, Hallm MA, Said T, Samhan M, Al-Mousawi M.

Transplant Proc. 2007 May;39(4):1207-10.

PMID:
17524934
41.

Oral valgancyclovir versus intravenous gancyclovir for cytomegalovirus prophylaxis in kidney transplant recipients.

Said T, Nampoory MR, Pacsa AS, Essa S, Madi N, Fahim N, Abraham M, Nair P, Al-Otaibi T, Halim MA, Johny KV, Al-Mousawi M.

Transplant Proc. 2007 May;39(4):997-9.

PMID:
17524873

Supplemental Content

Loading ...
Support Center